deals &amp dealmakers ipo outlook pharmasset ipo makes a flat debut new york the shares of health care company pharmasset inc the th health care company to go public on u s exchanges this year traded flat friday in its debut the initial public offering rose seven cents on the nasdaq stock market after pricing at the low end of an already reduced price range the shares ended at &# up from the &# offer price set by underwriters bank of america corp and ubs ag the princeton n j company also cut the size of the offer to five million shares from six million pharmasset focuses on the development of oral therapeutics for the treatment of hepatitis b hepatitis c and human immunodeficiency virus or hiv 
